MDM2 and cancer: It is also conceivable that these inhibitors or chemical compounds may be combined with MDM2-p53 interaction inhibitors and/or DNA damaging agents to increase the efficacy of p53-basad chemotherapy since they employ distinct mechanisms in inducing p53 in cancer cells.